Target intelligence / Profile preview

Paired-like homeodomain transcription factor 1 (PITX1)

Target
PITX1
Molecular classification
Transcription factor, Homeobox protein
01

Overview

Paired-like homeodomain transcription factor 1 (PITX1) is a sequence-specific transcription factor from the RIEG/PITX homeobox gene family, primarily involved in organ development—especially the hindlimb and pituitary gland.[1][3][4][5] It contains a conserved DNA-binding homeodomain and is essential for proper limb patterning, morphogenesis, and formation of specific tissues derived from the branchial arch (including jaw, palate, and parts of the ear).[4][5] PITX1 also modulates gene activity related to cell cycle regulation and apoptosis, interacting with major regulatory proteins like p53, E2F1, and Pin1, and impacts differentiation and proliferation.[3] Clinically, mutations or altered expression are associated with developmental syndromes (Liebenberg syndrome, clubfoot, cleft palate), and its dysregulation plays context-dependent roles as both tumor suppressor or oncogene in various cancers, marking it as a prognostic biomarker and emerging therapeutic target.[1][3] There are currently no targeted drugs or direct small-molecule modulators for PITX1.[3]

Other names
Pituitary homeobox 1BFTPTX1POTXHindlimb-expressed homeobox protein backfootHomeobox protein PITX1Paired-like homeodomain transcription factor 1CCFLBNBGpituitary homeobox 1hindlimb expressed homeobox protein backfootpituitary homeo box 1pituitary otx-related factor
02

Mechanism of action

No direct-acting drugs; mechanisms of hypothetical targeting include modulation of transcriptional activity and protein stability through phosphorylation, interaction with signaling proteins, and involvement in tumor suppressor pathways such as p53

03

Biological functions

Regulation of gene transcriptionOrgan developmentPatterning and morphogenesis of hindlimb structuresRegulation of pituitary gland developmentRegulation of cell cycle and apoptosisControl of bone, cartilage, muscle, and tendon development in lower limbsRegulation of noncoding RNA expression
04

Disease associations

CancerAutismClubfoot (autosomal dominant)PolydactylyLiebenberg syndromeCleft palateMandibular dysplasia
05

Safety considerations

Developmental toxicity (loss or inhibition linked to limb and craniofacial defects)Broad expression-pattern consequences (potential for off-target developmental/organ toxicity if disrupted)
06

Biomarkers

PITX1 expression (prognostic marker in certain cancers, e.g., downregulated in colon cancer, upregulated in lung cancer)

Beyond the preview

Go deeper on Paired-like homeodomain transcription factor 1 (PITX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paired-like homeodomain transcription factor 1 (PITX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call